Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

EFFECTS OF SMALL-SIDED GAME MANIPULATIONS ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL RESPONSES, PHYSICAL PERFORMANCE, AND TECHNICAL SKILLS IN FEMALE FOOTBALL PLAYERS

24. september 2026 oppdatert av: Bilal GÖK, Istanbul Gelisim University

THE EFFECT OF MANIPULATIONS APPLIED IN SMALL-SIDED GAMES ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL, PHYSICAL AND TECHNICAL PARAMETERS IN FEMALE FOOTBALLERS

Small-sided games will represent a prevalent component of branch-specific training methodologies in football. The objective of this study will be to examine the impact of small-sided games with sprint manipulation played in a 3v3 configuration on neuromuscular fatigue, along with physical, physiological, and technical parameters, in female football players.

The study will be conducted on a group of 12 female football players (experimental: 6, control: 6) who will have been actively playing licensed football for a minimum of three years. The participants will be asked to record their performance data over a six-week period, during which their physiological and physical parameters will be measured using Catapult (GPS) systems. The degree of neuromuscular fatigue will be determined through the active vertical jump test.

The data obtained from the study will be analysed using a Repeated Measures ANOVA test, with the significance level set at p < 0.05. Data analysis will be performed using the JASP 0.19.2 software package. It is expected that the results will reveal statistically significant differences in physiological parameters such as player load and perceived exertion level. In physical parameters, statistically significant differences are anticipated in total distance, positive acceleration, vertical jump performance, and running speed zones 1-2-3-4 (p < 0.05).

Consequently, the present study will aim to demonstrate that coaches may utilise this information in the organisation of training programmes to enhance performance parameters such as total distance covered, positive acceleration, and velocity, while simultaneously reducing neuromuscular fatigue in female football players.

Studieoversikt

Status

Fullført

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

12

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 23 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

Participants must be between the ages of 18 and 25. Participants must have played football at least three times. Participants must not have any health issues. Participants must voluntarily take part in the study.

Exclusion Criteria:

Participants not being between the ages of 18 and 25. Participants not having played licensed football for at least three years. Participants having a health issue.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Arm 1 (Experimental)

Sprint

In the study, the experimental group was exposed to sprint manipulation, unlike the control group.

Annen: Arm 2 (Control)

In the study, unlike the experimental group, the control group was given a 10-second recovery period.

In the study, unlike the experimental group, the control group was given a 10-second recovery period.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Neuromuscular Fatigue (Active Vertical Jump Height)
Tidsramme: Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)

Neuromuscular fatigue was assessed using the Active Vertical Jump Test (AVJT). Jump height was recorded in centimeters (cm) using a ForceDecks force platform. Each participant performed three trials with a two-minute rest between attempts, following a standardized warm-up protocol.

Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Perceived Exertion Level
Tidsramme: Baseline, Week 3, and Week 6

Perceived exertion was assessed using the Borg CR-10 Perceived Exertion Scale, scored from 1 (lowest) to 10 (highest), recorded 30 minutes after each training session.

Baseline, Week 3, and Week 6
Change in Maximum Heart Rate
Tidsramme: Baseline, Week 3, and Week 6

Maximum heart rate was recorded using the Polar Team Pro GPS system, expressed in beats per minute (bpm).

Baseline, Week 3, and Week 6
Change in Estimated Maximal Oxygen Uptake (VO2max)
Tidsramme: Baseline, Week 3, and Week 6

Aerobic capacity was estimated using the 30-15 Intermittent Fitness Test (Buchheit formula), expressed in ml/kg/min.

Baseline, Week 3, and Week 6
Change in Positive Acceleration
Tidsramme: Baseline, Week 3, and Week 6

Positive acceleration was recorded using the Polar Team Pro GPS system, expressed in meters per second squared (m/s²).

Baseline, Week 3, and Week 6
Change in Sprint Distance
Tidsramme: Baseline, Week 3, and Week 6

Sprint distance was recorded using the Polar Team Pro GPS system, expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Distance Covered per Running Speed Zone
Tidsramme: Baseline, Week 3, and Week 6

Distance covered was categorized into five speed zones using the Polar Team Pro GPS system: Zone 1 (0-6 km/h), Zone 2 (6.1-12 km/h), Zone 3 (12.1-15.4 km/h), Zone 4 (15.5-18.3 km/h), and Zone 5 (>18.4 km/h), expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Player Load
Tidsramme: Baseline, Week 3, and Week 6

Player load, a composite measure of physical demand, was recorded using the Polar Team Pro GPS tracking system, expressed in arbitrary units (AU).

Baseline, Week 3, and Week 6
Change in Total Distance Covered
Tidsramme: Baseline, Week 3, and Week 6

Total distance covered during small-sided games was recorded using the Polar Team Pro GPS system, expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Technical Performance Parameters
Tidsramme: Baseline, Week 3, and Week 6

Technical performance (accurate passes, inaccurate passes, dribbles, one-on-one battles, feints, and ball losses) was recorded via video analysis (GoPro Hero 12 Black) using computerized notational coding, expressed as count of actions.

Baseline, Week 3, and Week 6

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

20. mars 2024

Primær fullføring (Faktiske)

5. januar 2025

Studiet fullført (Faktiske)

28. april 2025

Datoer for studieregistrering

Først innsendt

7. mai 2026

Først innsendt som oppfylte QC-kriteriene

24. september 2026

Først lagt ut (Faktiske)

28. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

24. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 2024-01-107

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere